Table of Contents
<< Previous Issue | Aug 2018 (Vol: 2018, Issue: 8) | Next Issue >> |
- Section: Mergers & Acquisitions
-
Almirall Expands Pipeline with Allergan’s US Dermatology Portfolio in US$650 M Deal
-
Novo Nordisk Joins the Pack with Smart-Insulin Acquisition of Ziylo for US$800 M
- Section: Research & Development
-
Eli Lilly Signs Multi-Year Deal with Anima Biotech for Translation Inhibitors
-
Regeneron Forges a US$100 M Oncology Partnership with Bluebird Bio
-
BioNTech and Pfizer Join the mRNA Space in US$425 M Deal